Guan Lab
Democratizing accessible, affordable, accurate, and actionable diagnosis wherever and whenever needed
We develop cutting-edge biomedical devices, sensors, and systems that bring engineering, biology, and medicine together to solve healthcare challenges.
Who we are
We are a multidisciplinary team of engineers and scientists dedicated to integrating engineering, biology, and medicine to create innovative solutions for healthcare challenges. Our mission is to advance healthcare through research and groundbreaking innovation.
At our core, we believe in the transformative power of technology to enhance patient outcomes. Driven by this belief, we develop cutting-edge biomedical devices, sensors, and systems prioritizing efficiency, effectiveness, and accessibility for all. With a passion for tackling complex problems, we continuously explore new and innovative approaches to improve lives.
Research thrusts
Four connected thrusts take us from the molecule to the patient.
01 Point-of-Care & Self-Testing Diagnostics
Compact, sample-to-answer molecular tests that patients and health workers can run at home or in the field, connected to the cloud for real-time reporting.
- ViraLite HIV self-testing (2026)
- HIV/HCV self-testing (2025)
- LoRa wastewater surveillance (2026)
02 Solid-State Nanopore Sensing
Solid-state nanopores, from fabrication to label-free electrical readout, that count and size individual molecules for multiplexed nucleic acid testing.
- Nanopore cfDNA quality control (2025)
- Hydrogel glass nanopores (2025)
- CRISPR-Cas12a nanopores (2020)
03 Digital Molecular Assays
Assays that partition a sample into thousands of tiny reactions and count target molecules one by one, for absolute, calibration-free quantification.
- STAMP digital CRISPR (2023)
- Digital CRISPR review (2023)
- Droplet digital ELOHA (2015)
04 AI for Life Science
From machine learning that decodes biological and sensor signals to AI agents that plan experiments, run lab robots, and learn from the results.
- AI-decoded nanopore multiplexing (2026)
- Deep-learning fluorescence (2024)
- ML nanopore LAMP readout (2024)
Where we apply it
Infectious diseases
HIV, HCV, malaria, SARS-CoV-2, respiratory viruses, and mpox.
Alzheimer’s disease
Point-of-care tests for early detection and population screening.
Cardiovascular disease
Extending our diagnostic platforms to cardiovascular care.
Public-health surveillance
Networked monitoring of pathogens in communities and wastewater.
On-demand lab automation
Automated tools and instruments, from nucleic acid extraction to sample handling.
Our work in action